TOP
|
特許
|
意匠
|
商標
商標ウォッチ
Twitter
他の商標を見る
公開日
2024-12-18
公報種別
公開国際商標公報
国際登録番号
1816403
国際登録日
2024-08-27
区分
第5類(薬剤)
,
第42類(科学・技術)
,
第44類(医療・農林業)
商品役務
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.
,
Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; medical testing and clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.
,
Medical services; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information
,
consultancy and advisory services relating to the aforesaid.
基礎出願番号
UK00004024691
基礎出願日
2024-03-12
基礎出願国
GB
出願人
Bicycletx Limited
OCRテキスト
OCRテキスト2
B
OCRについて
この商標をJ-PlatPatで参照する
関連商標
久光製薬株式会社
ビーカップ B-CUP
2か月前
株式会社ファイン
リポホワイト LIPOWHITE
6か月前
武田薬品工業株式会社
?
6か月前
野口漢方合同会社
6か月前
獣医医療開発株式会社
ADEソリブル エーディーイーソリブル エーデーイーソリブル
6か月前
株式会社プランドゥ
VC. Liposome
6か月前
日本優の食品株式会社
VEANUT
6か月前
個人
EAA20
6か月前
大木製薬株式会社
Blood Brain Assist
6か月前
株式会社尚食ジャパンバイオロジー
胆EX
6か月前
株式会社尚食ジャパンバイオロジー
胆粉EX
6か月前
株式会社Kaya
Pululove
6か月前
小野薬品工業株式会社
BREAKTHROUGH EmbracetheChallengewithONO
6か月前
株式会社Kaya
Palalave
6か月前
小林薬品工業株式会社
レグトールEXαプラス
6か月前
トライズ株式会社
コンシェルジュドクター
6か月前
ミラティ セラピュ―ティックス,インク
KRAZATI
6か月前
ハウス食品グループ本社株式会社
AFTER
6か月前
ハウス食品グループ本社株式会社
ウコン UKONNOCHIKARA の力 AFTER
6か月前
綜美薬品株式会社
Rasayana ラサーヤナ
6か月前
株式会社MBDI
ステルスガード
6か月前
株式会社MBDI
Stealth Guard
6か月前
一般社団法人徳志会
飲むポテンツァ
6か月前
小林製薬株式会社
ダイレクトスプレー
6か月前
ユニ・チャーム株式会社
Recycle for the Future
6か月前
高山商事株式会社
RJU
6か月前
Blue Industries株式会社
DR.GENE
6か月前
Blue Industries株式会社
ドクタージーン
6か月前
Blue Industries株式会社
GENECARE
6か月前
Blue Industries株式会社
ジーンケア
6か月前
Blue Industries株式会社
genecounseling
6か月前
Blue Industries株式会社
ジーンカウンセリング
6か月前
個人
70%.
6か月前
株式会社栗原医療器械店
6か月前
高山商事株式会社
壬久
6か月前
株式会社ビバリア
ビバリア Vivaria
6か月前
続きを見る
他の商標を見る